NRG-GI012: Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer With Macrovascular Invasion (HELIO-RT)

Objective

This phase III trial compares the effect immunotherapy (IO) with stereotactic body radiation therapy (SBRT) to IO alone in treating patients with liver cancer (hepatocellular cancer) that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced).

National Clinical Trial (NCT) Number: 07166406

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT07166406

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Oncology Studies

Specialties

• Gastrointestinal Cancer

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]